In the BioHarmony Drug Report Database

"Preview" Icon

Glimepiride

Amaryl, Tandemact (glimepiride) is a small molecule pharmaceutical. Glimepiride was first approved as Amaryl on 1995-11-30. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.

 

Trade Name

 

Tandemact
 

Common Name

 

glimepiride
 

ChEMBL ID

 

CHEMBL1481
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Antihyperglycemics

Image (chem structure or protein)

Glimepiride structure rendering